Bank of New York Mellon
ICVX

Bank of New York Mellon’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Bank of New York Mellon’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-92,835
Closed -$1.46M – 4374
2023
Q4 		$1.46M Buy
92,835
+872
+0.9% +$8.4K ﹤0.01% 2983
2023
Q3 		$713K Buy
91,963
+7,210
+9% +$59.8K ﹤0.01% 3364
2023
Q2 		$842K Buy
84,753
+15,319
+22% +$123K ﹤0.01% 3305
2023
Q1 		$403K Sell
69,434
-954
-1% -$8.24K ﹤0.01% 3606
2022
Q4 		$559K Buy
70,388
+5,481
+8% +$23.5K ﹤0.01% 3487
2022
Q3 		$205K Buy
64,907
+6,972
+12% +$43.6K ﹤0.01% 4008
2022
Q2 		$332K Sell
57,935
-5,906
-9% -$46.1K ﹤0.01% 3827
2022
Q1 		$449K Buy
63,841
+25,741
+68% +$405K ﹤0.01% 3774
2021
Q4 		$872K Buy
38,100
+5,479
+17% +$141K ﹤0.01% 3464
2021
Q3 		$965K Buy
+32,621
New +$1.11M ﹤0.01% 3415

Bank of New York Mellon's ICVX Position: Q1 2024 in Review

Bank of New York Mellon sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 92,835 shares — an estimated $1.46M sold.

Bank of New York Mellon first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $1.46M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Bank of New York Mellon reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 92,835 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $1.46M.
  • Bank of New York Mellon first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
  • Bank of New York Mellon's Icosavax, Inc. Common Stock position peaked at $1.46M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.